Dr. Reddy's Laboratories
161 hedge funds and large institutions have $805M invested in Dr. Reddy's Laboratories in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 59 increasing their positions, 39 reducing their positions, and 17 closing their positions.
840% more call options, than puts
Call options by funds: $47K | Put options by funds: $5K
88% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 17
51% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 39
7% more funds holding
Funds holding: 151 → 161 (+10)
2.42% less ownership
Funds ownership: 49.11% → 46.7% (-2.4%)
6% less capital invested
Capital invested by funds: $857M → $805M (-$52M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$47.6M |
| 2 |
BlackRock
New York
|
+$7.84M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$7.17M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$6.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$27.4M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$17.5M |
| 3 |
JP Morgan Chase
New York
|
-$17.1M |
| 4 |
Goldman Sachs
New York
|
-$15.2M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$7.57M |
RDY Hedge Fund Activity: Q4 2022 in Review
161 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2022, worth a combined $805M — down 6.1% from $857M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new RDY positions and 17 closed out — a net gain of 15 holders — while 59 added to existing stakes and 39 trimmed.
The largest buyer was Robeco Institutional Asset Management, opening a new position worth an estimated $47.6M. The largest seller was Morgan Stanley, cutting an estimated $27.4M.
- 161 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2022, up from 151 in Q3 2022.
- Funds reported $805M of Dr. Reddy's Laboratories stock for Q4 2022, down 6.1% quarter-over-quarter.
- 32 funds opened new Dr. Reddy's Laboratories positions in Q4 2022 and 17 closed out, a net change of +15 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2022 was Robeco Institutional Asset Management, an estimated $47.6M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2022 was Morgan Stanley, an estimated $27.4M sold.
Based on aggregated 13F filings for Q4 2022.